Competitive Analysis of Microcrystalline Cellulose Market

Key Players

Competitive Landscape

Fourteen suppliers compete in microcrystalline cellulose, split between seven major global players and seven emerging names. Tablet makers give pharmaceutical grade work to producers with long qualification records, such as Roquette with the Avicel brand. Food and technical grades see sharper price competition.

Since May 2025 the MCC supplier group has seen an ownership change, capacity loss and capacity plans. Roquette absorbed IFF Pharma Solutions in May 2025. Sigachi lost about 6,000 metric tons per annum of capacity at Hyderabad and is building 12,000 metric tons per annum at Dahej-2. DFE Pharma moved into continuous manufacturing support with a recently launched platform. Dissolving pulp costs rose for all converters in H1 2026.

Company developments mapped to drivers, trends and opportunities (2026-2036)

Development Driver Trend Opportunity
May 2025: Roquette completed the IFF Pharma Solutions purchase. Scale in pharma excipients. Excipient brands consolidate. Cross-selling of MCC with HPMC and mannitol.
October 2025: Roquette opened the Barueri innovation center. Latin American drug makers need formulation help. Producers move technical service closer to buyers. Faster qualification of MCC grades in Brazil.
August 2026: Sigachi reported Dahej-2 progress on 12,000 tons per annum. Export demand from pharma customers. Indian capacity grows after the Hyderabad loss. More pharma-grade tonnage for US and European buyers.
September 2026: DFE Pharma showed a Continuous Manufacturing Platform. Drug makers adopt continuous lines. Excipients carry tighter specifications. Premium CM-ready MCC grades.

Source: Future Market Insights, Microcrystalline Cellulose Market Report, 2026-2036.

Converters work from one of two cost bases. Some buy dissolving pulp or linters under contract, and some rely on spot purchases. Lenzing said the Pulp Division generates roughly one quarter of the company's revenue from external sales.

Who leads the microcrystalline cellulose market?

Seven companies form the major group, namely IFF, Asahi Kasei, JRS PHARMA, DFE Pharma, Roquette Frères, Mingtai Chemical and Sigachi Industries. Roquette completed the IFF Pharma Solutions purchase in May 2025 and markets Avicel microcrystalline cellulose.

Which producers reported capacity or ownership moves since May 2025?

Roquette completed the IFF Pharma Solutions deal on 1 May 2025. Sigachi put cellulose-based excipient capacity at 18,000 tons per annum in August 2026. Lenzing cut Paskov pulp output by about 10% on limited wood supply.

What do tablet makers check before qualifying an MCC supplier?

Tablet makers check particle size, flow, moisture and nitrite levels first. Audit history, regulatory files and second-site backup come next. Price matters most for food and technical grades.

How will competition change through 2036?

Producers with own pulp or linter contracts will hold MCC prices, and spot buyers will chase volume. Indian suppliers will gain share in export pharma grades as Dahej-type expansions come online. Global excipient groups will bundle MCC with coatings, polymers and capsules to keep large accounts.

Representative Company Overview

Company Positioning Recent development
Roquette Frères Plant-based ingredients and excipients group May 2025: completed the IFF Pharma Solutions acquisition.
Sigachi Industries Indian MCC and cellulose excipient producer August 2026: Dahej-2 expansion to take capacity to 30,000 tons per annum.
DFE Pharma Excipient supplier with continuous manufacturing support September 2026: showed a Continuous Manufacturing Platform at CPHI Milan.

Research Methodology

Producer results and earnings calls, a pulp maker's half-year report and a Federal Register notice from May 2025 onward inform the analysis. The companies included in the report represent current market structure and do not indicate a market-share ranking.

Future Market Insights

Microcrystalline Cellulose Market